Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enterocolitis | 1 | 2021 | 106 | 0.660 |
Why?
|
| Enteritis | 1 | 2021 | 164 | 0.660 |
Why?
|
| Gastritis | 1 | 2021 | 199 | 0.630 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2021 | 205 | 0.570 |
Why?
|
| Eosinophilia | 1 | 2021 | 554 | 0.520 |
Why?
|
| Liver Transplantation | 3 | 2021 | 2416 | 0.450 |
Why?
|
| Liver Failure, Acute | 2 | 2021 | 182 | 0.320 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2022 | 94 | 0.200 |
Why?
|
| Ketotifen | 1 | 2021 | 24 | 0.180 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2021 | 75 | 0.180 |
Why?
|
| Biliary Atresia | 1 | 2021 | 88 | 0.170 |
Why?
|
| Budesonide | 1 | 2021 | 162 | 0.170 |
Why?
|
| Anti-Allergic Agents | 1 | 2021 | 153 | 0.160 |
Why?
|
| Plasma Cells | 1 | 2022 | 599 | 0.160 |
Why?
|
| Osmolar Concentration | 1 | 2020 | 654 | 0.160 |
Why?
|
| Hematologic Tests | 1 | 2020 | 239 | 0.160 |
Why?
|
| Postoperative Complications | 1 | 2021 | 15824 | 0.150 |
Why?
|
| Viremia | 1 | 2021 | 726 | 0.140 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 272 | 0.140 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2021 | 527 | 0.140 |
Why?
|
| Tacrolimus | 1 | 2021 | 751 | 0.140 |
Why?
|
| Hyperoxaluria, Primary | 1 | 2016 | 25 | 0.140 |
Why?
|
| Hepatitis, Alcoholic | 1 | 2018 | 110 | 0.130 |
Why?
|
| Transaminases | 1 | 2016 | 198 | 0.130 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2021 | 616 | 0.110 |
Why?
|
| Uric Acid | 1 | 2019 | 805 | 0.110 |
Why?
|
| Dermatitis, Atopic | 1 | 2021 | 734 | 0.110 |
Why?
|
| Neuroblastoma | 1 | 2021 | 1266 | 0.110 |
Why?
|
| Bone Marrow | 1 | 2022 | 2926 | 0.100 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2022 | 1665 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2021 | 2061 | 0.100 |
Why?
|
| Early Diagnosis | 1 | 2016 | 1188 | 0.090 |
Why?
|
| Hypersensitivity | 1 | 2021 | 1169 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2021 | 2163 | 0.090 |
Why?
|
| Glomerular Filtration Rate | 1 | 2019 | 2227 | 0.090 |
Why?
|
| Kidney Diseases | 1 | 2020 | 2099 | 0.080 |
Why?
|
| Coronary Angiography | 1 | 2020 | 4525 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 4210 | 0.070 |
Why?
|
| Graft Rejection | 1 | 2021 | 4498 | 0.070 |
Why?
|
| Contrast Media | 1 | 2020 | 5329 | 0.070 |
Why?
|
| Disease Progression | 2 | 2021 | 13646 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 2299 | 0.060 |
Why?
|
| Age Factors | 1 | 2021 | 18401 | 0.060 |
Why?
|
| Infant | 3 | 2021 | 36485 | 0.060 |
Why?
|
| Prevalence | 1 | 2021 | 15851 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 5693 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2021 | 42606 | 0.050 |
Why?
|
| Perforin | 1 | 2022 | 167 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39317 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 5389 | 0.050 |
Why?
|
| Granzymes | 1 | 2022 | 277 | 0.050 |
Why?
|
| Antigens, CD19 | 1 | 2022 | 443 | 0.040 |
Why?
|
| Risk Factors | 3 | 2021 | 74886 | 0.040 |
Why?
|
| Child | 3 | 2021 | 80771 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2021 | 65295 | 0.030 |
Why?
|
| Kidney Glomerulus | 1 | 2019 | 571 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2022 | 1894 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 13491 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2021 | 81659 | 0.030 |
Why?
|
| Consanguinity | 1 | 2016 | 460 | 0.030 |
Why?
|
| Fibrosis | 1 | 2021 | 2078 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 15645 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2022 | 2209 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2018 | 1824 | 0.030 |
Why?
|
| Humans | 10 | 2022 | 767040 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2019 | 1319 | 0.030 |
Why?
|
| Male | 5 | 2021 | 364203 | 0.020 |
Why?
|
| Female | 5 | 2021 | 396660 | 0.020 |
Why?
|
| Exons | 1 | 2016 | 2391 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 4560 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 3599 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 4892 | 0.020 |
Why?
|
| Liver | 1 | 2022 | 7578 | 0.020 |
Why?
|
| Patient Selection | 1 | 2018 | 4256 | 0.020 |
Why?
|
| Recurrence | 1 | 2018 | 8504 | 0.020 |
Why?
|
| Base Sequence | 1 | 2016 | 12414 | 0.020 |
Why?
|
| Mutation | 2 | 2021 | 30211 | 0.010 |
Why?
|
| Phenotype | 1 | 2022 | 16718 | 0.010 |
Why?
|
| Survival Rate | 1 | 2018 | 12823 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 9410 | 0.010 |
Why?
|
| Young Adult | 2 | 2019 | 59980 | 0.010 |
Why?
|
| Middle Aged | 3 | 2020 | 223233 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 6573 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29963 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2020 | 24299 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 41718 | 0.010 |
Why?
|
| Aged | 2 | 2019 | 171319 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 59548 | 0.010 |
Why?
|
| Adult | 2 | 2019 | 223317 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 89046 | 0.000 |
Why?
|
Concepts
(90)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_